Effects of asenapine on agitation and hostility in adults with acute manic or mixed episodes associated with bipolar I disorder

References

• VolavkaJViolence in schizophrenia and bipolar disorderPsychiatr Danub2013251243323470603
   PubMed Web of Science ®Google Scholar
• CorriganPWWatsonACFindings from the National Comorbidity Survey on the frequency of violent behavior in individuals with psychiatric disordersPsychiatry Res20051362–315316216125786
   PubMed Web of Science ®Google Scholar
• PulayAJDawsonDAHasinDSViolent behavior and DSM-IV psychiatric disorders: results from the national epidemiologic survey on alcohol and related conditionsJ Clin Psychiatry2008691122218312033
   PubMed Web of Science ®Google Scholar
• LatalovaKBipolar disorder and aggressionInt J Clin Pract200963688989919490199
   PubMed Web of Science ®Google Scholar
• GarnoJLGunawardaneNGoldbergJFPredictors of trait aggression in bipolar disorderBipolar Disord200810228529218271908
   PubMed Web of Science ®Google Scholar
• BarlowKGrenyerBIlkiw-LavalleOPrevalence and precipitants of aggression in psychiatric inpatient unitsAust N Z J Psychiatry200034696797411127627
   PubMed Web of Science ®Google Scholar
• BinderRLMcNielDEEffects of diagnosis and context on dangerousnessAm J Psychiatry198814567287323369561
   PubMed Web of Science ®Google Scholar
• NolanKAVolavkaJCzoborPAggression and psychopathology in treatment-resistant inpatients with schizophrenia and schizoaffective disorderJ Psychiatr Res200539110911515504429
   PubMed Web of Science ®Google Scholar
• CitromeLVolavkaJThe psychopharmacology of violence: making sensible decisionsCNS Spectr201419541141824571828
   PubMed Web of Science ®Google Scholar
• CitromeLInhaled loxapine for agitation revisited: focus on effect sizes from 2 Phase III randomised controlled trials in persons with schizophrenia or bipolar disorderInt J Clin Pract201266331832522226343
   PubMed Web of Science ®Google Scholar
• VolavkaJCzoborPCitromeLVan DornRAEffectiveness of antipsychotic drugs against hostility in patients with schizophrenia in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) studyCNS Spectr201419537438124284234
   PubMed Web of Science ®Google Scholar
• ZimbroffDLMarcusRNManosGManagement of acute agitation in patients with bipolar disorder: efficacy and safety of intramuscular aripiprazoleJ Clin Psychopharmacol200727217117617414241
   PubMed Web of Science ®Google Scholar
• OstacherMJSuppesTSwannACPatterns of response to aripiprazole, lithium, haloperidol, and placebo across factor scores of maniaInt J Bipolar Disord201531125945321
   PubMedGoogle Scholar
• KwentusJRiesenbergRAMarandiMRapid acute treatment of agitation in patients with bipolar I disorder: a multicenter, randomized, placebo-controlled clinical trial with inhaled loxapineBipolar Disord2012141314022329470
   PubMed Web of Science ®Google Scholar
• McIntyreRSCohenMZhaoJAlphsLMacekTAPanagidesJA 3-week, randomized, placebo-controlled trial of asenapine in the treatment of acute mania in bipolar mania and mixed statesBipolar Disord200911767368619839993
   PubMed Web of Science ®Google Scholar
• McIntyreRSCohenMZhaoJAlphsLMacekTAPanagidesJAsenapine in the treatment of acute mania in bipolar I disorder: a randomized, double-blind, placebo-controlled trialJ Affect Disord20101221–2273820096936
   PubMed Web of Science ®Google Scholar
• LandbloomRLMackleMWuXAsenapine: efficacy and safety of 5 and 10 mg bid in a 3-week, randomized, double-blind, placebo-controlled trial in adults with a manic or mixed episode associated with bipolar I disorderJ Affect Disord201619010311026496015
   PubMed Web of Science ®Google Scholar
• PrattsMCitromeLGrantWLesoLOplerLAA single-dose, randomized, double-blind, placebo-controlled trial of sublingual asenapine for acute agitationActa Psychiatr Scand20141301616824606117
   PubMed Web of Science ®Google Scholar
• YoungRCBiggsJTZieglerVEMeyerDAA rating scale for mania: reliability, validity and sensitivityBr J Psychiatry1978133429435728692
   PubMed Web of Science ®Google Scholar
• KaySRFiszbeinAOplerLAThe positive and negative syndrome scale (PANSS) for schizophreniaSchizophr Bull19871322612763616518
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. In: Washington DCDiagnostic and Statistical Manual of Mental DisordersFourth edSt. Louis, MOAmerican Psychiatric Association2000 Text Revision ed
   Google Scholar
• SheehanDVLecrubierYSheehanKHThe Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10J Clin Psychiatry199859suppl 202233 Quiz 34–57
   PubMed Web of Science ®Google Scholar
• MontoyaAValladaresALizanLSanLEscobarRPazSValidation of the Excited Component of the Positive and Negative Syndrome Scale (PANSS-EC) in a naturalistic sample of 278 patients with acute psychosis and agitation in a psychiatric emergency roomHealth Qual Life Outcomes201191821447155
   PubMed Web of Science ®Google Scholar
• SantorDAAscher-SvanumHLindenmayerJ-PObenchainRLItem response analysis of the Positive and Negative Syndrome ScaleBMC Psychiatry2007716618005449
   PubMed Web of Science ®Google Scholar
• AmonJSJohnsonSBEl-MallakhRSAsenapine for the control of physical aggression: a Prospective Naturalist Pilot StudyPsychopharmacol Bull2017471273228138201
   PubMedGoogle Scholar
• BuckleyPFPaulssonBBrecherMTreatment of agitation and aggression in bipolar mania: efficacy of quetiapineJ Affect Disord2007100suppl 1S33S4317376537
   PubMed Web of Science ®Google Scholar
• HsuWYHuangSSLeeBSChiuNYComparison of intramuscular olanzapine, orally disintegrating olanzapine tablets, oral risperidone solution, and intramuscular haloperidol in the management of acute agitation in an acute care psychiatric ward in TaiwanJ Clin Psychopharmacol201030323023420473056
   PubMed Web of Science ®Google Scholar
• MeehanKZhangFDavidSA double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar maniaJ Clin Psychopharmacol200121438939711476123
   PubMed Web of Science ®Google Scholar
• DundarYGreenhalghJRichardsonMDwanKPharmacological treatment of acute agitation associated with psychotic and bipolar disorder: a systematic review and meta-analysisHum Psychopharmacol Clin Exp2016314268285
   PubMed Web of Science ®Google Scholar
• El-MallakhRSMcKenzieCThe dopamine D4/D2 receptor antagonist affinity ratio as a predictor of anti-aggression medication efficacyMed Hypotheses201380553053323465625
   PubMed Web of Science ®Google Scholar
• CitromeLAsenapine review, part I: chemistry, receptor affinity profile, pharmacokinetics and metabolismExpert Opin Drug Metab Toxicol201410689390324793403
   PubMed Web of Science ®Google Scholar
• SakaueMAgoYSowaCModulation by 5-HT2A receptors of aggressive behavior in isolated miceJpn J Pharmacol2002891899212083749
   PubMedGoogle Scholar
• TakahashiAQuadrosIMde AlmeidaRMMiczekKABehavioral and pharmacogenetics of aggressive behaviorCurr Top Behav Neurosci2012127313822297576
   PubMedGoogle Scholar